Skip to Main Content

Advertisement

Skip Nav Destination

OnlineFirst

Clinical Trials: Targeted Therapy December 4 2023
Pilot Study of High-Dose Pemetrexed in Patients with Progressive Chordoma
Clin Cancer Res (2023)
Translational Cancer Mechanisms and Therapy December 4 2023
Combined Vorinostat and Chloroquine Inhibit Sodium–Iodide Symporter Endocytosis and Enhance Radionuclide Uptake In Vivo
Clin Cancer Res (2023)
Clinical Trials: Targeted Therapy December 4 2023
Olaparib plus Durvalumab, with or without Bevacizumab, as Treatment in PARP Inhibitor-Naïve Platinum-Sensitive Relapsed Ovarian Cancer: A Phase II Multi-Cohort Study
Clin Cancer Res (2023)
Precision Medicine and Imaging December 4 2023
Tumor Volume Growth Rates and Doubling Times during Active Surveillance of IDH-mutant Low-Grade Glioma
Clin Cancer Res (2023)
Precision Medicine and Imaging December 4 2023
Developing and Validating a Multivariable Prognostic-Predictive Classifier for Treatment Escalation of Oropharyngeal Squamous Cell Carcinoma: The PREDICTR-OPC Study
Clin Cancer Res (2023)
Research Briefs: Clinical Trial Brief Reports December 4 2023
A Phase II Basket Trial of Dual Anti–CTLA-4 and Anti–PD-1 Blockade in Rare Tumors (DART SWOG 1609 Cohort 47) in Patients with Gestational Trophoblastic Neoplasia
Clin Cancer Res (2023)
CCR Translations December 4 2023
PRESSING Need of Precision Care in HER2-Positive Colorectal Cancer: The ELEPHANT in the Room
Clin Cancer Res (2023)
CCR Translations December 4 2023
Exploiting Iron Metabolism as a Therapeutic Vulnerability in Glioblastoma
Clin Cancer Res (2023)
Perspective December 1 2023
Backfilling Patients in Phase I Dose Escalation Trials Using Bayesian Optimal Interval Design (BOIN)
Clin Cancer Res (2023)
Research Briefs: Precision Medicine and Therapeutics December 1 2023
TROP2 is associated with primary resistance to immune checkpoint inhibition in patients with advanced non-small cell lung cancer
Clin Cancer Res (2023)
Clinical Trial Brief Report December 1 2023
Evaluation of the SSTR2-targeted radiopharmaceutical 177Lu-DOTATATE and SSTR2-specific 68Ga-DOTATATE PET as imaging biomarker in patients with intracranial meningioma
Clin Cancer Res (2023)
Research Article December 1 2023
Aneuploidy Landscape in Precursors of Ovarian Cancer
Clin Cancer Res (2023)
CCR Translations December 1 2023
New T-cell therapies for brain metastasis, CD133 in the driver’s seat
Clin Cancer Res (2023)
CCR Translations December 1 2023
Pancreatic Cancer’s PD1-roadblock: When T-cell reinvigoration is not enough
Clin Cancer Res (2023)
Research Article November 30 2023
Clinical and Immunologic Features of Germline Pathogenic Variant (gPV) Positive Patients with Melanoma
Clin Cancer Res (2023)
Research Article November 30 2023
Clinical Benefit of Avapritinib in KIT-Mutant Gastrointestinal Stromal Tumors: A Post Hoc Analysis of the Phase I NAVIGATOR and Phase I/II CS3007-001 Studies
Clin Cancer Res (2023)
Review November 28 2023
Immunotherapy of MSI Cancer: Facts and Hopes
Clin Cancer Res (2023)
Clinical Trials: Targeted Therapy November 28 2023
Phase I Dose-Escalation Study of the Safety and Pharmacokinetics of AGS15E Monotherapy in Patients with Metastatic Urothelial Carcinoma
Clin Cancer Res (2023)
Clinical Trials: Targeted Therapy November 28 2023
Overall Survival and Exploratory Biomarker Analyses of Abemaciclib plus Trastuzumab with or without Fulvestrant versus Trastuzumab plus Chemotherapy in HR+, HER2+ Metastatic Breast Cancer Patients
Clin Cancer Res (2023)
Precision Medicine and Imaging November 28 2023
PET/CT Biomarkers Enable Risk Stratification of Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma Enrolled in the LOTIS-2 Clinical Trial
Clin Cancer Res (2023)
Translational Cancer Mechanisms and Therapy November 28 2023
FAK Drives Resistance to Therapy in HPV-Negative Head and Neck Cancer in a p53-Dependent Manner
Clin Cancer Res (2023)
Precision Medicine and Imaging November 28 2023
Comprehensive DNA Methylation Profiling of Medullary Thyroid Carcinoma: Molecular Classification, Potential Therapeutic Target, and Classifier System
Clin Cancer Res (2023)
Translational Cancer Mechanisms and Therapy November 28 2023
Tumor-Infiltrating CD103+ Tissue-Resident Memory T Cells and CD103CD8+ T Cells in HNSCC Are Linked to Outcome in Primary but not Metastatic Disease
Clin Cancer Res (2023)
Translational Cancer Mechanisms and Therapy November 28 2023
Landscape of Baseline and Acquired Genomic Alterations in Circulating Tumor DNA with Abemaciclib Alone or with Endocrine Therapy in Advanced Breast Cancer
Clin Cancer Res (2023)
Review November 28 2023
Facts and Hopes in Neoadjuvant Immunotherapy: Current Approvals and Emerging Evidence
Clin Cancer Res (2023)
Review November 28 2023
Translational Aspects of Epithelioid Sarcoma: Current Consensus
Clin Cancer Res (2023)
Review November 28 2023
Fine-Tuning Adjuvant Endocrine Therapy for Early-Stage Breast Cancer: An Expert Consensus on Open Issues for Future Research
Clin Cancer Res (2023)
Research Article November 27 2023
Modulating gut microbiota prevents anastomotic leak to reduce local implantation and dissemination of colorectal cancer cells after surgery
Clin Cancer Res (2023)
CCR Drug Updates November 27 2023
FDA Approval Summary: Ivosidenib in Combination with Azacitidine for Treatment of Patients with Newly Diagnosed Acute Myeloid Leukemia with an IDH1 Mutation
Clin Cancer Res (2023)
Research Article November 22 2023
Platinum-based chemotherapy attenuates the effector response of CD8 T cells to concomitant PD-1 blockade
Clin Cancer Res (2023)
Research Article November 22 2023
Development of resistance to type II JAK2 inhibitors in MPN depends on AXL kinase and is targetable
Clin Cancer Res (2023)
Research Article November 22 2023
A Phase I/II Study of GSK525762 Combined With Fulvestrant in Patients With Hormone Receptor-Positive/HER2-Negative (HR+/HER2−) Advanced or Metastatic Breast Cancer
Clin Cancer Res (2023)
CCR Translations November 21 2023
The Dance Between Tumor Molecular Biology and Antitumor Immune Response
Clin Cancer Res (2023)
Precision Medicine and Imaging November 21 2023
Intraoperative Integrated Diagnostic System for Malignant Central Nervous System Tumors
Clin Cancer Res (2023)
Translational Cancer Mechanisms and Therapy November 21 2023
Proteomic Profiling of Advanced Melanoma Patients to Predict Therapeutic Response to Anti-PD-1 Therapy
Clin Cancer Res (2023)
Precision Medicine and Imaging November 21 2023
A Fully Automated Deep-Learning Model for Predicting the Molecular Subtypes of Posterior Fossa Ependymomas Using T2-Weighted Images
Clin Cancer Res (2023)
Precision Medicine and Imaging November 21 2023
PHF6-altered T-ALL Harbor Epigenetic Repressive Switch at Bivalent Promoters and Respond to 5-Azacitidine and Venetoclax
Clin Cancer Res (2023)
Translational Cancer Mechanisms and Therapy November 21 2023
Landscape of Clinical Resistance Mechanisms to FGFR Inhibitors in FGFR2-Altered Cholangiocarcinoma
Clin Cancer Res (2023)
Special Report November 21 2023
Novel Approach to Accelerate Lung Cancer Research: Lung-MAP and the Potential of Public-Private Partnerships
Clin Cancer Res (2023)
CCR Translations November 21 2023
Uncovering the Potential of CD40 Agonism to Enhance Immune Checkpoint Blockade
Clin Cancer Res (2023)
Research Article November 20 2023
A Phase I Study of the CDK4/6 Inhibitor, Palbociclib in Combination with Cetuximab and Radiotherapy (IMRT) for Locally Advanced Head and Neck Squamous Cell Carcinoma
Clin Cancer Res (2023)
Research Article November 20 2023
Phase 1 study of Elraglusib (9-ING-41), a glycogen synthase kinase-3b inhibitor, as monotherapy or combined with chemotherapy in patients with advanced malignancies
Clin Cancer Res (2023)
Research Article November 20 2023
A Phase 1b First-In-Patient Study Assessing the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Ponsegromab in Participants with Cancer and Cachexia
Clin Cancer Res (2023)
Research Article November 20 2023
Selective DNA-PK inhibition enhances chemotherapy and ionizing radiation activity in soft-tissue sarcomas
Clin Cancer Res (2023)
Translational Cancer Mechanisms and Therapy November 20 2023
A PERK-Specific Inhibitor Blocks Metastatic Progression by Limiting Integrated Stress Response–Dependent Survival of Quiescent Cancer Cells
Clin Cancer Res (2023)
Research Article November 17 2023
Phase I/IIa trial in advanced pancreatic ductal adenocarcinoma treated with cytotoxic drug-packaged, EGFR-targeted nanocells and glycolipid-packaged nanocells
Clin Cancer Res (2023)
Research Article November 16 2023
First-in-Human Study with preclinical data of BCL-2/BCL-xL Inhibitor Pelcitoclax in Locally Advanced or Metastatic Solid Tumors
Clin Cancer Res (2023)
Research Article November 15 2023
SAR-096: Phase II clinical trial of ribociclib in combination with everolimus in advanced dedifferentiated liposarcoma (DDL), and leiomyosarcoma (LMS)
Clin Cancer Res (2023)
Research Article November 15 2023
Preclinical Characterization of AZD9574, a Blood-Brain Barrier Penetrant Inhibitor of PARP1
Clin Cancer Res (2023)
Research Article November 15 2023
Detection of recurrence through microRNA-371a-3p serum levels in a follow-up of stage I testicular germ cell tumors in the DRKS-00019223 study
Clin Cancer Res (2023)
Page 1 of 3
Close Modal

or Create an Account

Close Modal
Close Modal